Purpose The use of cyclosporine and mini-dose methotrexate (MTX) is a common strategy for graft-versus-host disease (GVHD) prophylaxis in allogeneic transplants. We investigated whether patients who receive fewer than the planned MTX doses are at increased risk for GVHD. MethodsThe study cohort included 103 patients who received allogeneic transplants at the Department of Pediatrics of The Catholic University of Korea College of... |